Newsletter

Biotech

Latest
Drug capsules on a table spelling out the acronym HIV.

Lenacapavir Shows Efficacy in Treating Multidrug Resistant HIV-1 Infection

Cancer researchers standing in a laboratory.

Nkarta Reports First-in-Human Infusion of NKX101 for Acute Myeloid Leukemia

Four syringes resting on a blue surface.

Jounce Presents Preclinical Data for LILRB2 Inhibitor JTX-8064

White pills resting on a yellow surface.

BTK Inhibitor Rilzabrutinib Shows Efficacy in Immune Thrombocytopenia

A person holding a syringe.

KIT Inhibitor CDX-0159 Shows Potential As Therapy for Mast Cell Diseases

Red, white, and yellow pills resting on a pink surface.

JAK1 Inhibitor Filgotinib Shows Efficacy in Treatment of Psoriatic Arthritis

Laboratory flasks resting on a surface.

Jounce Regains Worldwide Rights to LILRB2 Inhibitor JTX-8064 from BMS

A physician holding a syringe.

CAR-T Therapy Yescarta Leads to High Response Rate in Non-Hodgkin Lymphoma

A person holding a test for the coronavirus that causes COVID-19.

Altimmune To Initiate Phase 1/2 Clinical Trial of COVID-19 Therapy T-COVID

A person in a laboratory removing a syringe from a container.

Novavax Expands Manufacturing Capacity by Acquiring Praha Vaccines

123...5Page 1 of 5

Contact

Connect

Follow Us

ImmunoFrontiers LLC © 2019-2022. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

error: Content is protected.